Potential clinical utility of ERC-2 yeast phase lysate antigen for antibody detection in dogs with blastomycosis
- PMID: 30544205
- DOI: 10.1093/mmy/myy137
Potential clinical utility of ERC-2 yeast phase lysate antigen for antibody detection in dogs with blastomycosis
Abstract
Four Blastomyces antigens ERC-2 (B. gilchristii, dog, Wisconsin), B5929 (human, Minnesota), 597 (human, Wisconsin), and T-27 (polar bear, Tennessee) were tested against 31 serum specimens from dogs with blastomycosis and 19 from healthy dogs. All antigens detected antibody; efficacy varied. ERC-2 showed the highest ELISA mean absorbance value of 3.00 followed by T-27. Test performance varied by sample geographic origin. Further study is needed to determine if ERC-2 antigens may be clinically useful, and whether the combination of the particular fungal species as antigen source, host animal, and the species and geographic location of the patient being tested is important for optimum test characteristics.
Keywords: Blastomyces; antigens, fungal; blastomycosis; enzyme-linked immunosorbent assay.
© The Author(s) 2018. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources